Several systematic reviews also indicated that GLP-1RAs are consistently effective at reducing body weight [25, 41, 42, 44], supporting the nonglycaemic role of this agent class [44], as opposed to the weight gain that commonly accompanies insulin treatment [44]
But it has since been eclipsed by the semaglutide brands Ozempic for type 2 diabetes and Wegovy for obesity
Virtual Results Review: A follow-up telehealth visit to go over your lab results and finalize your treatment plan
GLP-1 agonists are also quite expensive and often in short supply due to high demand
Although society tends to normalize period pain, intense pain is not normal, and you deserve relief
You can get enrolled in retatrutide trials by visiting clinicaltrials.gov